EUVIMEDEUVIMED entdecken
Open Access

Global identification of SWI/SNF targets reveals compensation by EP400

Benjamin J E Martin, Eileen F Ablondi, Christine Goglia, Claudia A Mimoso, Piero R Espinel-Cabrera, Karen Adelman

Cell · 2023-11 · 186 (24) · 5290-5307.e26

DOI: 10.1016/j.cell.2023.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2023-11. Verfasst von Benjamin J E Martin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at H…. Hauptthemen laut MEDLINE: Nuclear Proteins, Transcription Factors. Die Arbeit wurde bisher 104-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Canadian Institutes of Health Research, Harvard Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear ProteinsTranscription FactorsAnimalsHumansChromatinChromatin Assembly and DisassemblyNucleosomesMiceDNA HelicasesDNA-Binding Proteins

Stichwörter der Autor:innen

BRG1EP400PRO-seqRNAPIISWI/SNFchromatin accessibilitychromatin remodelingcombination therapiesepigenetic regulatorstranscription

Substanzen

ChromatinNuclear ProteinsNucleosomesTranscription FactorsEp400 protein, mouseDNA HelicasesDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA.
  • Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cam…

Förderung

  • NIGMS NIH HHS
  • Canadian Institutes of Health Research
  • Harvard Medical School
  • National Science Foundation
  • Harvard Medical School Ludwig Center at Harvard
  • Novartis Institutes for BioMedical Research
  • Novartis Pharmaceuticals Corporation
  • Harvard University

Zitieren

APA

Martin, B. J. E., Ablondi, E. F., Goglia, C., Mimoso, C. A., Espinel-Cabrera, P. R., & Adelman, K. (2023). Global identification of SWI/SNF targets reveals compensation by EP400. Cell, 186(24), 5290-5307.e26. https://doi.org/10.1016/j.cell.2023.10.006

Vancouver

Martin BJE, Ablondi EF, Goglia C, Mimoso CA, Espinel-Cabrera PR, Adelman K. Global identification of SWI/SNF targets reveals compensation by EP400. Cell. 2023;186(24):5290-5307.e26. doi:10.1016/j.cell.2023.10.006

BibTeX
@article{Martin2023,
  author = {Martin, Benjamin J E and Ablondi, Eileen F and Goglia, Christine and Mimoso, Claudia A and Espinel-Cabrera, Piero R and Adelman, Karen},
  title = {Global identification of SWI/SNF targets reveals compensation by EP400},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {24},
  pages = {5290--5307.e26},
  doi = {10.1016/j.cell.2023.10.006}
}
Kostenlos starten →